Concepedia

I. Gaultier

IG

Statistics

Publications

5

Citations

205

H-Index

5

Active since

2010

Affiliations

Hospital Civil de Guadalajara(Current)

I. Gaultier is an author at Hospital Civil de Guadalajara specializing in antiviral therapy, molecular virology, and antiviral agents.

Publications per year

2010–2014

5

Publications

5

<i>In Vitro</i> and <i>In Vivo</i> Antiviral Activity and Resistance Profile of the Hepatitis C Virus NS3/4A Protease Inhibitor ABT-450

Rakesh Tripathi, Daniel E. Cohen, I. Gaultier et al. · Antimicrobial Agents and Chemotherapy · 2014 · 117 citations

Life Sciences, Infectious Diseases, Pharmacology +17

Similar Safety and Efficacy of Once- and Twice-Daily Lopinavir/Ritonavir Tablets in Treatment-Experienced HIV-1–Infected Subjects at 48 Weeks

Roberto Zajdenverg, Thomas Podsadecki, Sharlaa Badal‐Faesen et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2010 · 34 citations

Medicine, Pharmacology, Pharmacotherapy +17

1206 ABT-072 OR ABT-333 COMBINED WITH PEGYLATED INTERFERON/RIBAVIRIN AFTER 3-DAY MONOTHERAPY IN HCV GENOTYPE 1 (GT1)-INFECTED TREATMENT-NAIVE SUBJECTS: 12-WEEK SUSTAINED VIROLOGIC RESPONSE (SVR12) AND SAFETY RESULTS

F. Poordad, E. Läwitz, E DeJesus et al. · Journal of Hepatology · 2012 · 21 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

1187 ABT-450/RITONAVIR (ABT-450/R) COMBINED WITH PEGYLATED INTERFERON ALPHA-2A/RIBAVIRIN AFTER 3-DAY MONOTHERAPY IN GENOTYPE 1 (GT1) HCV-INFECTED TREATMENT-NAIVE SUBJECTS: 12-WEEK SUSTAINED VIROLOGIC RESPONSE (SVR12) AND SAFETY RESULTS

E. Läwitz, F. Poordad, E DeJesus et al. · Journal of Hepatology · 2012 · 19 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +16

1229 GENOTYPIC AND PHENOTYPIC CHARACTERIZATION OF NS3 VARIANTS SELECTED IN HCV-INFECTED PATIENTS TREATED WITH ABT-450

Rakesh Tripathi, Tatyana Dekhtyar, Rajeev Menon et al. · Journal of Hepatology · 2011 · 14 citations · Full text

Life Sciences, Genetics, Infectious Diseases +10

1–5 of 5